Renal damage associated with silicon compounds in dogs

Area of Science:

• Toxicology
• Pharmacology
• Materials Science

Background:

• Silicon compounds are widely used in various commercial preparations, including those for human consumption.
• Understanding the toxicological profile of different silicon forms is crucial for public health.
• Sodium silicate and magnesium trisilicate are common ingredients in products with potential human exposure.

Purpose of the Study:

• To evaluate the toxicological effects of different oral silicon preparations in animal models.
• To identify potential adverse effects, particularly on renal function and structure.
• To compare the safety profiles of silicon dioxide, sodium silicate, magnesium trisilicate, and aluminium silicate.

Main Methods:

• Young adult Beagle dogs and rats of both sexes were administered various oral silicon preparations for four weeks.
• Animals were monitored for clinical signs, and blood and urine samples were analyzed.
• Comprehensive necropsy and histopathological examinations were performed on all animals post-sacrifice.

Main Results:

• Polydipsia, polyuria, and soft stools were observed in some dogs and rats receiving sodium silicate and magnesium trisilicate.
• Blood and urine analyses remained within normal limits for all tested animals.
• Gross and microscopic renal lesions were identified in dogs treated with sodium silicate and magnesium trisilicate, but not in those given silicon dioxide or aluminium silicate.
• No lesions were observed in any of the rats, irrespective of the silicon compound administered.

Conclusions:

• Sodium silicate and magnesium trisilicate may induce renal toxicity in dogs.
• Silicon dioxide and aluminium silicate appear to be safe when administered orally at the tested doses.
• The potential renal effects of sodium silicate and magnesium trisilicate warrant further investigation due to their prevalence in human-use products.